<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>alpha-Difluoromethylornithine, an enzyme-activated irreversible inhibitor of <z:chebi fb="0" ids="18257">ornithine</z:chebi> decarboxylase, was administered in combination with human leukocyte interferon to human lymphoblastoid (Daudi) cells in culture </plain></SENT>
<SENT sid="1" pm="."><plain>True synergistic antiproliferative activity was observed at 72 hr after continuous exposure </plain></SENT>
<SENT sid="2" pm="."><plain>This effect was observed regardless of the ratio of interferon to alpha-difluoromethylornithine concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>Although the mechanisms by which this effect occurs are unknown, these studies provide a rationale for combination clinical trials of alpha-difluoromethylornithine with leukocyte interferon </plain></SENT>
</text></document>